Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Forte

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1983
Model for mammalian metallothionein structureY Boulanger, C M Goodman, C P Forte, et al.
Journal of Virology|November 1, 1991
Mechanisms of receptor-mediated rhinovirus neutralization defined by two soluble forms of ICAM-1J M Greve, C P Forte, C W Marlor, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 1998
An immune cell-selective interleukin 4 agonistA B Shanafelt, C P Forte, J J Kasper, et al.
Blood|February 7, 2001
Interleukin-4 variant (BAY 36-1677) selectively induces apoptosis in acute lymphoblastic leukemia cellsK Srivannaboon, A B Shanafelt, E Todisco, et al.
Cell|March 10, 1989
The major human rhinovirus receptor is ICAM-1J M Greve, G Davis, A M Meyer, et al.
Medicina Oral, Patologia Oral Y Cirugia Bucal|April 14, 2024
Comparison of a daily and alternate-day photobiomodulation protocol in the prevention of oral mucositis in patients undergoing radiochemotherapy for oral cancer: a triple-blind, controlled clinical trialF-M Oliveira, M-M Borges, C-E Malta, et al.
Nature Biotechnology|November 4, 2000
A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivoA B Shanafelt, Y Lin, M C Shanafelt, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1983
Model for mammalian metallothionein structureY Boulanger, C M Goodman, C P Forte, et al.
Journal of Virology|November 1, 1991
Mechanisms of receptor-mediated rhinovirus neutralization defined by two soluble forms of ICAM-1J M Greve, C P Forte, C W Marlor, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 1998
An immune cell-selective interleukin 4 agonistA B Shanafelt, C P Forte, J J Kasper, et al.
Blood|February 7, 2001
Interleukin-4 variant (BAY 36-1677) selectively induces apoptosis in acute lymphoblastic leukemia cellsK Srivannaboon, A B Shanafelt, E Todisco, et al.
Cell|March 10, 1989
The major human rhinovirus receptor is ICAM-1J M Greve, G Davis, A M Meyer, et al.
Medicina Oral, Patologia Oral Y Cirugia Bucal|April 14, 2024
Comparison of a daily and alternate-day photobiomodulation protocol in the prevention of oral mucositis in patients undergoing radiochemotherapy for oral cancer: a triple-blind, controlled clinical trialF-M Oliveira, M-M Borges, C-E Malta, et al.
Nature Biotechnology|November 4, 2000
A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivoA B Shanafelt, Y Lin, M C Shanafelt, et al.
Pageof 1